BIONIKK: A phase 2 biomarker driven trial with nivolumab and ipilimumab or VEGFR tyrosine kinase inhibitor (TKI) in naïve metastatic kidney cancer

Author:

Epaillard Nicolas,Simonaggio Audrey,Elaidi Reza,Azzouz Fouzia,Braychenko Elena,Thibault Constance,Sun Cheng-Ming,Moreira Marco,Oudard Stéphane,Vano Yann-Alexandre

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Reference17 articles.

1. Synthèse – Estimations nationales de l’incidence et de la mortalité par cancer en France métropolitaine entre 1990 et 2018 – Ref : SYNINCNAT2019 [Internet]. [cité 1 avr 2020]. Available from: https://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Synthese-Estimations-nationales-de-l-incidence-et-dela-mortalite-par-cancer-en-France-metropolitaine-entre-1990-et-20182

2. Molecular subtypes of clear cell renal cell carcinoma are associated with sunitinib response in the metastatic setting;Beuselinck;Clin Cancer Res Off J Am Assoc Cancer Res,2015

3. Prognostic and theranostic impact of molecular subtypes and immune classifications in renal cell cancer (RCC) and colorectal cancer (CRC);Becht;Oncoimmunology,2015

4. Clear-cell Renal Cell Carcinoma: Molecular Characterization of IMDC Risk Groups and Sarcomatoid Tumors;Verbiest;Clin Genitourin Cancer,2019

5. European Medicines Agency – News and Events – New treatment for advanced form of kidney cancer [Internet]. [cité 19 sept 2016]. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/02/news_detail_002478.jsp&mid=WC0b01ac058004d5c1

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3